Biotech with Triangle operations pledges billions for U.S. manufacturing
The California company follows other drug companies to announce significant investments in the U.S. amid pressure from the Trump administration.
The California company follows other drug companies to announce significant investments in the U.S. amid pressure from the Trump administration. 
